| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,151 |
4,730 |
$433K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,145 |
4,816 |
$72K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,048 |
1,777 |
$58K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,011 |
1,747 |
$57K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
553 |
517 |
$54K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
507 |
466 |
$52K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,785 |
3,515 |
$30K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
261 |
245 |
$25K |
| 80053 |
Comprehensive metabolic panel |
1,854 |
1,645 |
$22K |
| 87081 |
|
3,134 |
2,932 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
923 |
871 |
$18K |
| 80061 |
Lipid panel |
1,103 |
1,062 |
$17K |
| 87653 |
|
553 |
494 |
$16K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
664 |
520 |
$16K |
| 88142 |
|
972 |
806 |
$16K |
| 80050 |
General health panel |
321 |
263 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,498 |
1,263 |
$12K |
| 87210 |
|
2,349 |
2,061 |
$10K |
| 85027 |
|
1,359 |
1,225 |
$10K |
| 87631 |
|
85 |
72 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
205 |
196 |
$9K |
| 81001 |
|
2,468 |
2,214 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
331 |
283 |
$8K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
239 |
214 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
610 |
553 |
$6K |
| 80306 |
|
301 |
247 |
$4K |
| 84439 |
|
297 |
279 |
$3K |
| 81025 |
|
400 |
379 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
332 |
305 |
$3K |
| 87634 |
|
34 |
33 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
108 |
76 |
$2K |
| 82043 |
|
200 |
194 |
$1K |
| 85610 |
|
262 |
179 |
$1K |
| 84702 |
|
55 |
41 |
$1K |
| 82947 |
|
222 |
213 |
$1K |
| 85652 |
|
333 |
284 |
$1K |
| 86850 |
|
208 |
197 |
$1K |
| 85018 |
|
258 |
248 |
$768.43 |
| 86900 |
|
203 |
190 |
$690.38 |
| 86901 |
|
202 |
190 |
$686.65 |
| 87077 |
|
82 |
66 |
$620.45 |
| 83690 |
|
49 |
49 |
$438.06 |
| 87070 |
|
59 |
53 |
$408.09 |
| 80076 |
|
40 |
36 |
$373.55 |
| 81003 |
|
94 |
91 |
$249.47 |
| 87205 |
|
62 |
52 |
$200.87 |
| 84550 |
|
33 |
27 |
$182.79 |
| 87186 |
|
15 |
15 |
$173.25 |
| 83735 |
|
19 |
13 |
$145.63 |
| 86140 |
|
19 |
17 |
$111.82 |
| 82565 |
|
21 |
14 |
$101.92 |
| 36415 |
Collection of venous blood by venipuncture |
26 |
24 |
$0.00 |